Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys.
Zuzana Justinova, Gianluigi Tanda, Godfrey H Redhi, Steven R Goldberg
Psychopharmacology September 2003 DOI: 10.1007/s00213-003-1484-0 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational animal study (intravenous self-administration experiment) Peer reviewed |
|---|---|
| Population | Drug-naive squirrel monkeys with no history of exposure to other drugs |
| Intervention | delta9-tetrahydrocannabinol (THC) |
| Dose | 1 to 16 microg/kg per injection (tested doses); 0.2 ml injections |
| Duration | Acquisition reached in 11-34 sessions; dose-response testing followed |
| Topics | Cannabis |
| Key findings | THC functioned as a reinforcer in drug-naive squirrel monkeys, sustaining intravenous self-administration above vehicle levels at 2, 4, and 8 micrograms per kilogram per injection, with maximal responding at 4 micrograms per kilogram. Response rates, injections per session, and total THC intake were two- to three-fold greater than in earlier monkeys with a history of cocaine self-administration, suggesting that prior drug exposure is not required for THC self-administration. |
Abstract
Interest in therapeutic activities of cannabinoids has been restrained by the fact that they are most often mediated through activation of cannabinoid CB1 receptors, the same receptors that mediate the effects of delta9-tetrahydrocannabinol (THC) and are responsible for the abuse liability of marijuana. Persistent intravenous self-administration of THC by animals was first demonstrated in squirrel monkeys and shown to be mediated by CB1 receptors, but monkeys in the study had a history of cocaine self-administration, raising the possibility that persistent neurobiological adaptations might subsequently predispose animals to self-administer THC. To demonstrate persistent intravenous self-administration of THC in drug-naive squirrel monkeys. Monkeys with no history of exposure to other drugs learned to press a lever for intravenous injections (0.2 ml in 0.2 s) of THC under a 10-response, fixed-ratio schedule with a 60-s time-out after each injection. Acquisition of THC self-administration was rapid and the final schedule was reached in 11-34 sessions. Dose of THC was then varied from 1 to 16 microg/kg per injection with vehicle extinction following each dose of THC. THC maintained significantly higher numbers of self-administered injections per session and higher rates of responding than vehicle at doses of 2, 4 and 8 microg/kg per injection, with maximal rates of responding at 4 microg/kg per injection. Response rates, injections per session and total THC intake per session were two- to three-fold greater in monkeys with no history of exposure to other drugs compared to previous findings in monkeys with a history of cocaine self-administration. THC can act as an effective reinforcer of drug-taking behavior in monkeys with no history of exposure to other drugs, suggesting that self-administration of THC by monkeys provides a reliable animal model of human marijuana abuse.
Comparable studies
Other preclinical and animal studies on cannabis, most cited first.
Citations in the library
Cited by 28
- Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines Journal of Neuroscience November 12, 2014
- Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review European Archives of Psychiatry and Clinical Neuroscience January 24, 2019
- Optogenetic brain‐stimulation reward: A new procedure to re‐evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter‐Cre mice Addiction Biology February 3, 2021
- Δ 9 -Tetrahydrocannabinol-induced enhancement of reward responsivity via mesocorticolimbic modulation in squirrel monkeys. bioRxiv : the preprint server for biology January 24, 2026
- Effects of sex and pre-exposure on Δ9-tetrahydrocannabinol (THC) vapor self-administration in rats. Psychopharmacology May 1, 2026
and 23 more in the library
Cites 3
- Endocannabinoid signaling in the brain. Science April 26, 2002
- Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science January 15, 1999
- Phencyclidine-like discriminative effects of opioids in the rat. Journal of Pharmacology and Experimental Therapeutics September 1, 1980